Global Allogeneic Cell Therapy Market Size & Trends Report Segmented by Source (Stem Cells, HSCs, MSCs, Non-stem Cell Therapies), Application (Oncology, Orthopedics, CVDs, Autoimmune Disorders), End User (Hospitals, ASCs) Forecast to 2030

1. Introduction
   • Introduction
   • Market Scope
     • Market Definition
     • Segments Covered
     • Regional Segmentation
   • Research Timeframe
   • Currency Considered
   • Study Limitations
   • Stakeholders
   • List of Abbreviations
   • Key Conferences and Events (2025-2026)
2. Research Methodology
   • Secondary Research
   • Primary Research
   • Market Estimation
     • Bottom-Up Approach
     • Top-Down Approach
   • Market Forecasting
3. Executive Summary
   • Allogeneic Cell Therapy Marke"4">
   • Market Overview
     • Market Dynamics
     • Drivers
       • Growing demand for off-the-shelf therapies
       • Advancements in cell engineering and genomic technologies
       • Rising prevalence of chronic and rare diseases
       • Strong pipeline and clinical trials
     • Restraints
       • Immunogenicity and rejection risk
       • Complex manufacturing processes
       • High development costs and limited reimbursement
       • Ethical concerns and regulatory hurdles
     • Opportunities
       • Expansion into new indications
       • Emerging markets
       • Strategics collaborations and partnerships
       • Integration with advanced technologies
     • Key Market Trends
       • Growing focus on immuno-oncology
       • Manufacturing and scalability improvements
     • Unmet Market Needs
     • Industry Speaks
   • Global Allrket Size & Forecast (2023-2030), By Source, USD Million
     • Introduction
     • Stem Cell Therapies
       • Hematopoietic Stem Cell Therapies (HSCs)
       • Mesenchymal Stem Cell Therapies (MSCs)
       • Other Stem Cell Therapies
     • Non-stem Cell Therapies
       • T-Cell Therapies
       • Natural Killer (NK) Cell Therapies
       • Other Non-stem Cell Therapies
     • Others
   • Global Allogeneic Cell Therapy Market Size & Forecast (2023-2030), By Application, USD Million
     • Introduction
     • Oncology
     • Cardiovascular Diseases
     • Neurological Disorders
     • Autoimmune Diseases
     • Orthopaedic Disorders
     • Haematological Disorders
     • Others
   • Global Allogeneic Cell Therapy Market Size & Forecast (2023-2030), By Region, USD Million
     • Introduction
     • North Americy Market Size & Forecast (2023-2030), By Country, USD Million
       • US
         • Market Size & Forecast, By Source (USD Million)
         • Market Size & Forecast, By Application (USD Million)
       • Canada
         • Market Size & Forecast, By Source (USD Million)
         • Market Size & Forecast, By Application (USD Million)
     • Europe Allogeneic Cell Therapy Market Size & Forecast (2023-2030), By Country, USD Million
       • UK
         • Market Size & Forecast, By Source (USD Million)
         • Market Size & Forecast, By Application (USD Million)
       • Germany
         • Market Size & Forecast, By Source (USD Million)
         • Market Size & Forecast, By Application (USD Million)
       • France
         • Market Size & Forecast, By Source (USD Million)
         By Source (USD Million)
         • Market Size & Forecast, By Application (USD Million)
       • Spain
         • Market Size & Forecast, By Source (USD Million)
         • Market Size & Forecast, By Application (USD Million)
       • Rest of Europe
         • Market Size & Forecast, By Source (USD Million)
         • Market Size & Forecast, By Application (USD Million)
     • Asia Pacific (APAC) Allogeneic Cell Therapy Market Size & Forecast (2023-2030), By Country, USD Million
       • China
         • Market Size & Forecast, By Source (USD Million)
         • Market Size & Forecast, By Application (USD Million)
       • Japan
         • Market Size & Forecast, By Source (USD Million)
         • Market Size & Forecast, By Application (USD Million)
       • India
         >
       • Rest of Asia Pacific
         • Market Size & Forecast, By Source (USD Million)
         • Market Size & Forecast, By Application (USD Million)
     • Latin America (LATAM) Allogeneic Cell Therapy Market Size & Forecast (2023-2030), USD Million
       • Market Size & Forecast, By Source (USD Million)
       • Market Size & Forecast, By Application (USD Million)
     • Middle East & Africa (MEA) Allogeneic Cell Therapy Market Size & Forecast (2023-2030), USD Million
       • Market Size & Forecast, By Source (USD Million)
       • Market Size & Forecast, By Applicat"8">
       • Competitive Landscape
         • Key Players and their Competitive Positioning
           • Key Player Comparison
           • Segment-wise Player Mapping
           • Market Share Analysis (2024)
           • Company Categorization Matrix
             • Dominants/Leaders
             • New Entrants
             • Emerging Players
             • Innovative Players
           • Key Strategies Assessment, By Player (2023-2025)
             • New Product Launches
             • Partnerships, Agreements, & Collaborations
             • Mergers & Acquisitions
             • Geographic Expansion

9. Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

• Athersys, Inc.
• Mesoblast Ltd
• BioRestorative Therapies, Inc.
• Poseida Therapeutics, Inc.
• Vertex Pharmaceuticals Incorporated
• Fate Therapeutics
• Allogene Therapeutics
• Artiva Biotherapeutics, Inc.
• Atara Biotherapeutics, Inc.
• CRISPR Therapeutics
• Other Prominent Players

Note *Indicative list

**For listed companies